0001127602-22-025761.txt : 20221116
0001127602-22-025761.hdr.sgml : 20221116
20221116161959
ACCESSION NUMBER: 0001127602-22-025761
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221114
FILED AS OF DATE: 20221116
DATE AS OF CHANGE: 20221116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Babu Yarlagadda S
CENTRAL INDEX KEY: 0001452635
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 221395422
MAIL ADDRESS:
STREET 1: 2190 PARKWAY LAKE DR
CITY: BIRMINGHAM
STATE: AL
ZIP: 35244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-11-14
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001452635
Babu Yarlagadda S
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Chief Discovery Officer
Common Stock
2022-11-14
4
M
0
50000
1.42
A
280056
D
Common Stock
2022-11-14
4
M
0
50000
1.42
A
330056
D
Common Stock
2022-11-14
4
S
0
31515
13.88
D
298541
D
Emp. Stock Option (Right to Buy)
1.42
2022-11-14
4
M
0
50000
0
D
2014-01-01
2023-01-01
Common Stock
50000
0
D
Emp. Stock Option (Right to Buy)
1.42
2022-11-14
4
M
0
50000
0
D
2014-01-01
2023-01-01
Common Stock
50000
0
D
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.86 to $13.92. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Annual Employee Option Grant became exercisable in four equal annual installments, beginning on this date.
Retention Employee Stock Option became exercisable in two equal annual installments, beginning on this date.
/s/ Alane P. Barnes, by power of attorney
2022-11-16